Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and the European leader in non-invasive prenatal testing (NIPT), announces that it has signed an agreement with ...

Natera says it has begun making good on its priorities for 2021, which include expansions in noninvasive prenatal testing (NIPT), transplant rejection testing, minimal residual disease (MRD) cancer ...

SAN CARLOS, Calif., Aug. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive prenatal testing, announced a joint guideline released yesterday by the American College of ...

The birth of every new life is to be celebrated. During the first trimester of pregnancy, doctors from the department of gynecology and obstetrics may suggest pregnant mothers undertake noninvasive ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Analysis, Market Size, Test Analysis, Country Outlook, Growth Potential, ...

In December 2022, the American College of Medical Genetics and Genomics made a recommendation that all expectant mothers should be offered non-invasive prenatal testing (NIPT) instead of traditional ...

Natera is a leading company in the field of molecular diagnostics, capitalizing on the growing potential and widespread application in modern healthcare. The company has a proven track record and ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Mexico Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...

(MENAFN- GlobeNewsWire - Nasdaq) Rising demand for early genetic screenings, technological advancements, and increased awareness are key growth drivers. With improved prenatal care and expanded ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Sept. 2, 2024 /PRNewswire/ -- The global Non-invasive Prenatal Testing (NIPT) Market is valued at ...